← Leaderboards
Michael A Dyer
St. Jude Children'S Research Hospital
$24,988,379
Attributed
$24,988,379
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,988,379 · 13
By mechanism
R01$20,924,370 · 10
U01$3,632,740 · 1
P30$250,691 · 1
R03$180,578 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Claudia Andrea Benavente$3,328,001
- Jacqueline Norrie$202,014
- Charles W Roberts$21,463,141
- Catherine A Regni$40,850
Others in their field
Top investigators on “Persons”
- Wafaa M. El-Sadr · Columbia University Health Sciences$688,439,560
- Lawrence Corey · Fred Hutchinson Cancer Center$646,462,796
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- David R. Weir · University Of Michigan At Ann Arbor$386,183,647
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$377,922,183
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$265,384,316
Research focus
PersonsGovernmentResearch ProposalsTumorClinical TrialsCellsS Research HospitalAffectSaint Jude Children&AposEvaluationIn VivoChildMolecularRetinoblastomaNeoplastic CellBiologySeriesRetinaClinically RelevantDesignComplexPreclinical TestingMalignant Childhood NeoplasmVision
Grant awards (69)
In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas$767,363
U01 · FY2025 · CA · contact PI
The Role of Müller Glia in Acute and Chronic Response to Stress, Injury, and Disease in the Retina$606,034
R01 · FY2025 · EY · contact PI
The Role of Modular Super-Enhancers in the Developing Murine and Human Retina$596,514
R01 · FY2025 · EY · contact PI
Developmental Biology and Solid Tumor Program$60,140
P30 · FY2025 · CA · contact PI
In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas$767,363
U01 · FY2024 · CA · contact PI
The Role of Modular Super-Enhancers in the Developing Murine and Human Retina$596,514
R01 · FY2024 · EY · contact PI
Novel Therapeutic Approaches for the Treatment of Neuroblastoma$390,077
R01 · FY2024 · CA · contact PI
Modeling Retinoblastoma Initiation Using 3D-Retinal Organoids$390,077
R01 · FY2024 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Neuroblastoma$37,460
R01 · FY2024 · CA · contact PI
In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas$578,635
U01 · FY2023 · CA · contact PI
Cell-typeâ and developmental stageâspecific regulation of gene expression in the retina$448,750
R01 · FY2023 · EY · contact PI
Modeling Retinoblastoma Initiation Using 3D-Retinal Organoids$402,394
R01 · FY2023 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Neuroblastoma$402,394
R01 · FY2023 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Neuroblastoma$126,486
R01 · FY2023 · CA · contact PI
Developmental Biology and Solid Tumor Program$38,612
P30 · FY2023 · CA · contact PI
In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas$752,016
U01 · FY2022 · CA · contact PI
Cell-typeâ and developmental stageâspecific regulation of gene expression in the retina$435,287
R01 · FY2022 · EY · contact PI
Modeling Retinoblastoma Initiation Using 3D-Retinal Organoids$402,394
R01 · FY2022 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Neuroblastoma$402,394
R01 · FY2022 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Neuroblastoma$129,069
R01 · FY2022 · CA · contact PI
Developmental Biology and Solid Tumor Program$38,612
P30 · FY2022 · CA · contact PI
In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas$767,363
U01 · FY2021 · CA · contact PI
Cell-typeâ and developmental stageâspecific regulation of gene expression in the retina$435,287
R01 · FY2021 · EY · contact PI
Modeling Retinoblastoma Initiation Using 3D-Retinal Organoids$410,606
R01 · FY2021 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Rhabdomyosarcoma$410,606
R01 · FY2021 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Neuroblastoma$410,606
R01 · FY2021 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Neuroblastoma$89,637
R01 · FY2021 · CA · contact PI
Developmental Biology and Solid Tumor Program$37,342
P30 · FY2021 · CA · contact PI
Cell-typeâ and developmental stageâspecific regulation of gene expression in the retina$448,750
R01 · FY2020 · EY · contact PI
Modeling Retinoblastoma Initiation Using 3D-Retinal Organoids$410,606
R01 · FY2020 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Neuroblastoma$410,606
R01 · FY2020 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Rhabdomyosarcoma$410,606
R01 · FY2020 · CA · contact PI
Developmental Biology and Solid Tumor Program$38,612
P30 · FY2020 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Rhabdomyosarcoma$398,287
R01 · FY2019 · CA · contact PI
Developmental Biology and Solid Tumor Program$37,373
P30 · FY2019 · CA · contact PI
Novel Therapeutic Approaches for the Treatment of Rhabdomyosarcoma$410,606
R01 · FY2018 · CA · contact PI
Epigenetic Reprogramming of Retinal Neurons$437,500
R01 · FY2017 · EY · contact PI
Novel Therapeutic Approaches for the Treatment of Rhabdomyosarcoma$410,606
R01 · FY2017 · CA · contact PI
Epigenetic Reprogramming of Retinal Neurons$437,500
R01 · FY2016 · EY · contact PI
Molecular Targeted Therapy for Retinoblastoma$363,125
R01 · FY2016 · CA · contact PI
Epigenetic Reprogramming of Retinal Neurons$428,750
R01 · FY2015 · EY · contact PI
Molecular Targeted Therapy for Retinoblastoma$363,125
R01 · FY2015 · CA · contact PI
Epigenetic Reprogramming of Retinal Neurons$428,750
R01 · FY2014 · EY · contact PI
Molecular Targeted Therapy for Retinoblastoma$352,231
R01 · FY2014 · CA · contact PI
Epigenetic Reprogramming of Retinal Neurons$437,500
R01 · FY2013 · EY · contact PI
Molecular Targeted Therapy for Retinoblastoma$341,338
R01 · FY2013 · CA · contact PI
Cell type-specific roles of Rb in retinal differentiation$399,168
R01 · FY2012 · EY · contact PI
Molecular Targeted Therapy for Retinoblastoma$363,125
R01 · FY2012 · CA · contact PI
Proliferation and Differentiation of Retinal Stem Cells$403,200
R01 · FY2011 · EY · contact PI
Cell type-specific roles of Rb in retinal differentiation$399,168
R01 · FY2011 · EY · contact PI
The role of tumor suppressor Rb in horizontal neuron development$54,162
R03 · FY2011 · TW · contact PI
Proliferation and Differentiation of Retinal Stem Cells$506,915
R01 · FY2010 · EY · contact PI
Cell type-specific roles of Rb in retinal differentiation$415,800
R01 · FY2010 · EY · contact PI
The role of tumor suppressor Rb in horizontal neuron development$54,708
R03 · FY2010 · TW · contact PI
Cell type-specific roles of Rb in retinal differentiation$514,077
R01 · FY2009 · EY · contact PI
Proliferation and Differentiation of Retinal Stem Cells$420,000
R01 · FY2009 · EY · contact PI
Cell type-specific roles of Rb in retinal differentiation$313,663
R01 · FY2009 · EY · contact PI
Cell type-specific roles of Rb in retinal differentiation$94,077
R01 · FY2009 · EY · contact PI
Proliferation and Differentiation of Retinal Stem Cells$92,032
R01 · FY2009 · EY · contact PI
The role of tumor suppressor Rb in horizontal neuron development$71,708
R03 · FY2009 · TW · contact PI
Proliferation and Differentiation of Retinal Stem Cells$610,000
R01 · FY2008 · EY · contact PI
Cell type-specific roles of Rb in retinal differentiation$420,000
R01 · FY2008 · EY · contact PI
Proliferation and Differentiation of Retinal Stem Cells$420,000
R01 · FY2008 · EY · contact PI
Proliferation Control in the Retina: The Rb Family$394,725
R01 · FY2007 · EY · contact PI
Proliferation Control in the Retina: The Rb Family$396,948
R01 · FY2006 · EY · contact PI
Proliferation Control in the Retina: The Rb Family$406,500
R01 · FY2005 · EY
Proliferation Control in the Retina: The Rb Family$337,500
R01 · FY2004 · EY
Proliferation Control in the Retina: The Rb Family$67,500
R01 · FY2004 · EY
Proliferation Control in the Retina: The Rb Family$337,500
R01 · FY2003 · EY